These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3994460)

  • 1. Clinical effects and side effects of amrinone. A study of 24 patients with chronic congestive heart failure.
    Silverman BD; Merrill AJ; Gerber L
    Arch Intern Med; 1985 May; 145(5):825-9. PubMed ID: 3994460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study.
    DiBianco R; Shabetai R; Silverman BD; Leier CV; Benotti JR
    J Am Coll Cardiol; 1984 Nov; 4(5):855-66. PubMed ID: 6386932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study.
    Evans JR; Pacht K; Huss P; Unverferth DV; Bashore TM; Leier CV
    Int J Clin Pharmacol Res; 1984; 4(1):9-18. PubMed ID: 6381344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
    Robinson PJ; Lvoff R; Chong B; Barrett PA
    Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
    Massie B; Bourassa M; DiBianco R; Hess M; Konstam M; Likoff M; Packer M
    Circulation; 1985 May; 71(5):963-71. PubMed ID: 3886191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amrinone in acute and long-term therapy].
    Klepzig M; Kleinhans E; Büll U; Strauer BE
    Z Kardiol; 1985 Feb; 74(2):85-90. PubMed ID: 3922139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of amrinone administered orally and by injection in heart failure].
    Bounhoure JP; Massabuau P; Puel J; Miquel JP; Calazel J
    Ann Med Interne (Paris); 1985; 136(3):251-5. PubMed ID: 3896092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with amrinone in patients with advanced congestive heart failure.
    Kinney EL; Carlin B; Ballard JO; Burks JM; Hallahan WF; Zelis R
    J Clin Pharmacol; 1982 Oct; 22(10):433-40. PubMed ID: 7174853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amrinone-mediated thrombocytopenia.
    Kinney EL; Ballard JO; Carlin B; Zelis R
    Scand J Haematol; 1983 Oct; 31(4):376-80. PubMed ID: 6622977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amrinone in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS; Sutton MS; Wilson H; Rocci ML
    J Am Coll Cardiol; 1984 May; 3(5):1282-90. PubMed ID: 6707381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative vasoactive therapy for heart failure.
    Benotti JR; McCue JE; Alpert JS
    Am J Cardiol; 1985 Jul; 56(3):19B-24B. PubMed ID: 4025154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA
    Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties.
    Bottorff MB; Rutledge DR; Pieper JA
    Pharmacotherapy; 1985; 5(5):227-37. PubMed ID: 3906583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
    Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
    Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Milrinone, a new agent for the treatment of congestive heart failure.
    Hasegawa GR
    Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytopenia and fever in a patient taking amrinone.
    Rubin SA; Lee S; O'Connor L; Hubenette A; Tober J; Swan HJ
    N Engl J Med; 1979 Nov; 301(21):1185. PubMed ID: 492292
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Circulation; 1984 Dec; 70(6):1038-47. PubMed ID: 6388899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic effects of amrinone.
    Goldstein RA; Gray EL; Dougherty AH; Naccarelli GV
    Am J Cardiol; 1985 Jul; 56(3):25B-28B. PubMed ID: 4025155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral amrinone in refractory congestive heart failure.
    Wynne J; Malacoff RF; Benotti JR; Curfman GD; Grossman W; Holman BL; Smith TW; Braunwald E
    Am J Cardiol; 1980 Jun; 45(6):1245-9. PubMed ID: 7377123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.